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Abstract
Background: The surgical treatment of upper cervical spine metastases are controversial up to now. By summarizing
and analyzing the clinical data of the upper cervical spine involved metastases treated surgically in our center, we
mainly aimed to investigate the surgical decisions and outcomes so as to provide more references for the clinical
treatment of this special and complex spine metastasis.
Methods: We evaluated the patients’ pre- and post-operative neck pain and neurologic function with paired t test,
followed by the statistics of the selection of surgical approaches, ways of reconstruction, and related complications.
Moreover, the Kaplan–Meier survival analysis was adopted to analyze the patients’ survival according to different
growth group (rapid, moderate, and slow).
Results: There were 39 patients with atlantoaxial metastases in this study. The most common symptom (94.87%) was
occipital-cervical pain, which relieved greatly after surgical interventions (p < 0.01). The metastases mainly resulted
from lung cancer and nasopharyngeal cancer with an incidence of 38.46 and 10.26%, respectively. As to different
growth group, the rapid-growth tumors accounted for 69.23% in all atlantoaxial metastases. Tumor resection and
stabilization were performed mainly via the combined anterior and posterior approach (66.67%). The 1-, 2-, and
3-year overall survival rate at the last follow-up was 58.5, 40, and 28.3%, respectively, with a median survival time of
18 months. The rate of complications associated with the surgical intervention was 12.82% (5/39), which is lower than
that of the previous reports and generally controllable.
Conclusions: Relatively radical interventions with surgery for upper cervical spine metastases offered satisfactory
outcomes with a low mortality. Together with adjuvant therapy, surgical treatment benefits patients with atlantoaxial
metastases by relieving regional pain, restoring or improving the neurologic function, stabilizing the quality of life, and
prolonging the survival time of such patients.
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Background
The spine is the most common location of bone metas-
tasis with an incidence of 70% in terminal cancer
patients [1], including 8–25% in the cervical spine [2],
while only about 0.5% in the upper cervical spine [3].
Studies about upper cervical metastases treatments are
limited to case reports or small series [4–12]. Atlantoaxial
metastasis usually not only results in severe neck pain
[1, 7–9, 11, 13–15] but also leads to serious consequences
such as paralysis of high position and death [7–9, 11].
Atlantoaxial metastasis generally involve the anterior
elements, which is similar to tumors of the subaxial cer-
vical spine. Treatment options for atlantoaxial metastases
have always been controversial and difficult due to the
great difficulty in exposure, resection, and reconstruction
as a result of the complex anatomies. Irradiation, halo vest
or collar support, or posterior-only decompression, and
stabilization are the common treatments for such
* Correspondence: cnspineyang@163.com; jianruxiao83@163.com
†Equal contributors
Department of Orthopedic Oncology, Changzheng Hospital, Second Military
Medical University, 415 Fengyang Road, Shanghai 200003, China
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yang et al. World Journal of Surgical Oncology  (2017) 15:21 
DOI 10.1186/s12957-016-1085-0
metastases [6–11]. Due to the critical position of the upper
cervical spine, progression of the tumors would occur and
cord compression even life-threatening events could
be inevitable [9, 11, 16]. Although conservative treat-
ment has a limited effect in symptoms relief and
prognosis [9, 11, 13, 17], studies about the attempt of
tumor resection and reconstruction in patients with
upper cervical spine metastasis are hardly found up
to now [4, 12, 18].
In the present study, we retrospectively analyzed
the clinical features, pathologies, and the approaches,
reconstructions, and outcomes of surgical treatment
for atlantoaxial metastases in an attempt to provide
new references for the treatment of upper cervical
metastases. To the best of our knowledge, this is the
largest study that focuses on the surgical treatment of
atlantoaxial metastasis.
Methods
Among the 4158 patients of spinal tumor from 2002 to
2014, the patients who were treated surgically for meta-
static involvement of atlas and/or axis in our center were
retrospectively analyzed in this study (Table 1). Pain was
assessed pre- and post-operatively using the visual
analog scale (VAS), which has a score scale of 0–10.
In addition, the neurologic function was assessed ac-
cording to the Frankel grade. According to the results
of PET-CT scan or emission computed tomography,
the Tomita scoring system was used in all patients to
evaluate the condition of metastasis at admission.
Kaplan–Meier survival analysis was conducted in all
the patients as well as in different (rapid, moderate,
and slow) growth groups.
Our indications for surgery were (1) severe occipital-
cervical pain or significant fracture with atlantoaxial
displacement; (2) failure of conservative treatment
such as radiotherapy, chemotherapy, or targeted ther-
apy; (3) occurrence of serious neurologic deficits; (4) to
make histopathologic analysis of unknown primary tumor;
(5) estimated survival time longer than 6 months; and
(6) a tolerable general condition for surgery [4, 5].
Selections of surgical approaches and reconstruc-
tions generally depended on the location of the lesion
as shown on pre-operative CT and MRI. A high cer-
vical anterior approach (retropharyngeal) was adopted
for patients with tumors that predominantly involved
the C2 vertebral bodies or anterior arch and lateral
mass of C1, while the posterior approach was per-
formed in most patients for tumor resection and occi-
pitocervical fusion. For patients treated with a combined
approach, the anterior approach was done first (ex-
cept case 28) to ensure the sufficient exposure of the
anterior elements.
Post-operative course
The trachea cannula was removed on the first day after
operation in six patients and immediately after operation
in the other patients. Adjuvant therapies were required
according to the pathologies and pre-operative treat-
ments (Table 1). All patients were required to stay in
bed for about 3–4 weeks and wear the orthosis for at
least 3 months. The follow-up evaluations were made
regularly at 3, 6, and 12 months in the first year, then
every 6 months or annually.
Results
Clinical findings
The patient demographics were summarized in Table 1.
There were 29 males and 10 females (2.9:1), with a mean
age of 55 (8–80) years. Neck pain, as the most common
symptom, was complained by 37 (94.87%) of the 39 pa-
tients. Numbness or weakness of the upper limbs and
pre-operative dysphagia were found only in 6 cases
(Table 1). Only one patient (case 29) had the symptom
of cord compression. The amount of solitary metastasis
(C1 or C2), both metastasis (C1 and C2), and multiple
metastasis involving the upper cervical spine were 15,
11, and 13 cases, respectively.
The primary sites of our cases were the lung in 15
(38.46%), nasopharynx in 4 (10.26%), and liver, thyroid,
kidney, and bone (osteosarcoma) in 3 patients (7.69%),
respectively (Fig. 1). Surprisingly, in 20 (51.3%) of the in-
cluded patients, the symptoms of cervical metastases
were the first presentations of primary malignant dis-
eases, which are greatly different from the findings in
previous studies [7, 11]. According to the Tomita scoring
system, tumors of rapid growth group including lung
cancer, nasopharyngeal carcinoma, hepatic cancer,
osteosarcoma, and bladder carcinoma occupied about
69.23% (27/39). There were 7 patients in 2–3 points,
9 in 4–5 points, 11 in 6–7 points, and 11 in 8–10
points (Table 2). The mean pre-operative VAS was
6.46, and the pre-operative neurologic functions were
grade D in 9 patients, E in 29 patients, and C in only
one patient (Table 1).
Treatments and outcomes
With strict pre-operative assessment, all surgeries were
completed successfully without serious intraoperative
complications. Perioperative death occurred in one pa-
tient based on the World Health Organization (WHO)
definition as death within 30 days after surgery. In broad
terms, tumor resection was mainly conducted via the
combined anterior retropharyngeal and posterior ap-
proach (66.67%), and the posterior approach was per-
formed in 97.44% except one patient (case 11). Tumors
were removed by piecemeal resection in 31 (79.49%)
patients and subtotal resection in 8 (20.51%) patients. As
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to reconstruction, anterior reconstruction with autolo-
gous or allogeneic iliac crest bone grafts or bone cement
and titanium mesh cages were performed in 6 patients,
posterior reconstruction with occipitocervical fusion in
28 (71.79%) patients, and the remaining 5 patients were
reconstructed with the combination of them.
All patients with pre-operative neck pain except the
dead one experienced reduced or total relief of neck pain
(97.30%), which is similar to the results in other studies
[13, 19]. Paired t test of the pre-operative and post-
operative VAS showed a great significance (p < 0.01) at
3 months follow-up with a post-operative VAS of 0.95.
The neurologic function was recovered or improved
after operation in all patients and did not show deterior-
ation during the follow-up period (Table 1).
By the end of the follow-up period, 30 (76.92%) cases
died mainly due to progression of systemic cancer, with
no death due to local cord compression. Excluding the
perioperative death, the survival time of others ranged
from 3 to 138 months with a mean of 22 months.
According to the Kaplan–Meier estimates (Fig. 2a), the
median post-operative survival time was 18 months after
surgery. The 1-, 2-, and 3-year overall survival (OS) was
58.5, 40, and 28.3%, respectively. The prognosis was rela-
tively favorable in the slow-growth group, with a median
survival of 60 months vs. 18 months in the rapid-growth
group (Fig. 2b). Surprisingly, the prognosis in the
moderate-growth group was poorer than that in the
rapid-growth group, which probably due to the limited
cases. The 1-year survival rate in patients with slow-
growth primary tumors was 72.9% vs. 55.3% in patients
with rapid-growth primary tumors. It is amazing that
the 2-year survival rate was 41.5% in patients with rapid-
growth primary tumors. The results of different Tomita
scores showed a mean of 29 months in 2–3 points,
33 months in 4–5 points, 17 months in 6–7 points, and
13 months in 8–10 points, with an excellent median
survival range of 7–60 months (Table 2, Fig. 3).
Generally, no more serious complication occurred in
our series except that the patient who developed dyspnea
after the tracheal extubation and died of airway obstruc-
tion at last. Another with dyspnea recovered well after
emergent tracheotomy. There was still another patient
who suffered posterior wound dehiscence and healed after
debridement, while the other patient with wound dehis-
cence after the evacuation of hematoma failed to heal and
died 6 months after operation due to the systemic tumor
progression. No infection was noted in neither of them.
Post-operative dysphagia and dysphonia occurred in
two patients and vanished gradually without special
intervention (Table 1). There was no other perioperative
complications such as instrumentation failure, injury of
the vertebral artery, neurologic deterioration, and cerebro-
spinal fluid leak in any of the remaining patients.
Discussion
Significance of surgical treatment
Atlantoaxial metastasis is a rare clinical occurrence,
accounting for about 0.5% of all spinal metastases. Up to
now, the treatment choices of such metastases are con-
troversial, especially in terms of the surgical approaches,
reconstruction, and the extent. Here, we mainly aimed
to investigate the surgical decisions and outcomes so as
to provide more references for the treatment of this
special and complex metastasis through sharing our
experience of treating upper cervical spine metastases.
Patients with atlantoaxial metastases may remain
asymptomatic for a long time because of the wide diam-
eter of the upper cervical spinal canal [16]. Pain, which
can be intolerable in some cases, is the most common
pre-operative symptom [1, 7–9, 11, 13–15], as was in
our study (94.87%). Instability is the main reason for
pain, which usually cannot be relieved completely by
radiotherapy alone [17]. Instead of surgical resection,
relative conservative therapy used to be the main choice
for atlantoaxial metastasis primarily because of the lim-
ited life expectancy, high risks of surgery, and inad-
equacy of the techniques available [6–11]. Of course,
once the failure of conservative therapies, progression of
tumors, or limited relief of symptoms occur, more
serious complications even death were inevitable and
surgeries may be required at last [9, 11, 13, 16, 17]. In
our series, though some complications may occur, the
anterior surgery is recommended since the failure
Fig. 1 Pathologies proportion of the 39 atlantoaxial metastases
Table 2 Survival time of different Tomita scoring groups
Tomita scoring Cases Mean survival (mos) Median survival (mos)
2–3 points 7 29 60
4–5 points 9 33 47
6–7 points 11a 17 18
8–10 points 11 13 7
aThe dead patient was excluded from this group
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possibility of conservative therapies and the relatively
low rate of complications. Here, eight of the 39 patients
were admitted to our center for the ineffective relief of
the symptoms by adjuvant therapies. Therefore, we rec-
ommend to proceeding relatively aggressive tumor
resection (Fig. 4) to reduce the low mortality since the
advances of surgical techniques today and the significant
low rate of complications.
Pain relief is usually the earliest outcome in the treat-
ment of upper cervical metastasis, as reported in previous
studies [7–11]. Similarly, pain relief in our presentation
was extremely excellent (100%) with a mean VAS of 0.95
after operation vs. 6.45 before operation (p < 0.01), which
improves patients’ quality of life greatly. Survival is
another important consideration in deciding whether to
perform surgery or not and the extent of surgery for upper
cervical metastasis. More reports [11, 13, 16, 20] have
showed that surgery can help achieve better prognosis and
survival than palliative or conservative interventions for
cervical and other spinal metastases.
Fig. 2 a Kaplan–Meier curve of 38 atlantoaxial metastases showed that the overall survival rates at 1, 2, and 3 years after surgery were 58.5, 40,
and 28.3%, respectively. b Kaplan–Meier curves of different growth groups in atlantoaxial metastases showed that the median survival rates of
slow, moderate, and rapid growth group were 60, 18, and 10 months, respectively
Fig. 3 The survival time of different Tomita scoring groups
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In our series, the average survival time of the 38 (except
the perioperative death) patients was 22 months, longer
than that of other studies of cervical metastases with a
mean survival of 6–19 months [1, 4, 7, 8, 10, 19, 21–23].
Yet, Kirchner et al. [5] reviewed all the metastases to the
cranio-cervical junction with a mean survival time of
6.44 months. In addition, the median survival time in our
series was 18 months, and the 1- and 2-year OS was 58.5
and 40%, respectively, which were better than the 1-year
OS of 58% and 2-year OS of 21% reported by Heidecke
et al. [22], and the 1-year OS of 33% reported by Fourney
et al. [10]. Although the Tomita scores were high in about
50% of our cases, the overall outcome was satisfactory
as represented by a mean survival rate of 13 months.
It was obvious that surgical treatment benefit patients
of atlantoaxial metastasis greatly in spite of the high
Tomita scores.
Surgical approach
There are controversies over the selection of surgical
approaches for upper cervical spine tumors. Ideally, the
optimal surgical approach should be the one that can
provide access to all components for convenient resec-
tion and reconstruction without causing injury to the
vital structures. In general, the tumor location, the ex-
tent of location, the patient’s general condition, potential
complications, and surgical experience are critical fac-
tors affecting the decision on the selection of surgical
modalities. In previous studies, the posterior approach
alone was performed mainly for the purpose of regional
Fig. 4 One case with C2 metastasis (thyroid cancer) suffered serious pain for half a year. a The posterior occipitalcervical fixation was conducted
only when he was first adopted into another hospital. b He came to our center for unrelieved continuous neck pain. We performed the tumor
resection through an anterior-posterior approach, followed by the spine reconstruction without complication. c The last follow-up at 11 months
without recurrence and discomfort
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stabilization [5–8, 11]. Various approaches can give
access to the atlantoaxial lesions, including the trans-
mandibular, transoral, anterolateral, posterolateral, high
anterior cervical, combined pre-vascular and retrovascular
extraoral, posterior, and the combined anterior and pos-
terior approach [4, 24–26].
Similar to tumors of the subaxial cervical spine,
atlantoaxial metastases generally involve the anterior
elements (WBB, section 4–9). The anterior approach
for resection of upper cervical tumors in this location
is essential in most cases but was infrequently used
in atlantoaxial metastases before [4–8, 11, 26]. Maxil-
lotomy, transmandibular, and transoral approach were
seldom used in atlantoaxial metastases since compli-
cations such as large trauma, infections, and delayed
union are the most common problems [27, 28]. The
high anterior cervical approach avoids the infection
risk of the transmandibular and transoral approach,
and also allows for enough exposure to tumors of lat-
eral mass, anterior arch, odontoid process, and C2
vertebra. In this study, we employed the high anterior
cervical approach for all the anterior resection. Our
practice and other studies [4, 25, 29] have demon-
strated that the high anterior cervical approach is
effective to perform tumor resection and reconstruc-
tion in this region.
In our study, the posterior approaches with or without
occipitocervical fusion were performed in 31 and 7 cases
respectively (Table 1). The posterior approach, especially
occipitocervical fixation, seems to be inevitable for upper
cervical spine tumors to keep the stabilization in this
region [5, 8, 10, 14]. Certainly, posterior fixation alone
without the occiput can also be considered for C2 alone
tumors [30, 31].
Although en bloc resection is now recommended as
the optimal therapeutic option for spine tumor [32], it is
difficult to be performed in the upper cervical spine. For
metastases of the upper cervical spine, we prevailingly
performed piecemeal resection for most of the patients
due to the complexed anatomies. At last follow up, no
further neurologic deterioration was observed in our pa-
tients. It was obvious that total piecemeal resection plays
an important and useful role for atlantoaxial metastasis.
Reconstructions
Reconstruction after atlantoaxial tumor resection is
another problem in terms of the method and material
[30, 31]. For atlantoaxial lesions, early surgeons per-
formed anterior reconstructions with bone grafts fixed
to anterior arch or clivus or combination of bone
grafts, plates, and screws, but neither of them was
sufficient [33]. In recent years, the titanium mesh
cage with or without plate modified types and prosthesis
have been employed to gain solid reconstruction in this
region [30, 34]. For lesions involving the anterior struc-
tures of the atlas, reconstruction seems to be more diffi-
cult and insufficient. Given this situation, we performed
the surgeries without anterior reconstruction in this case
for the possible complications induced by failure of in-
ternal fixation. In our opinion which was proved by prac-
tices, removal of the anterior arch and one of the lateral
mass will not affect the stability significantly with the help
of occipitocervical fusion. In addition, for patients treated
with a combined approach, we preferred to perform the
anterior approach first (except case 28) in case that
occipitalcervical fusion may prevent from sufficient
exposure for resection and reconstruction of the anterior.
Pathology
As shown in Fig. 1, the most common atlantoaxial
metastasis was seen in lung cancer, followed by nasopha-
ryngeal, hepatic, thyroid, renal cancer, and osteosarcoma.
Unlike breast cancer, metastases in lung and prostate
cancer mainly involve cervical or upper cervical spine
[4, 7, 9–11, 22], and the rapid-growth tumors rank
the most (69.23%). As a result, the prognosis varied
in different growth groups as mentioned above (Fig. 2).
This reminded us that relative aggressive surgical
resection was worthy for upper cervical metastases,
especially for the slow-growth group.
Complications
Complications of atlantoaxial tumors treatments are
usually weighted carefully in decision-making of surgical
or non-surgical treatment, Complications associated to
the surgical treatments including injury of the spinal
cord, hemorrhage, dyspnea, wound infection, and fix-
ation failure are various and deadly [8–10]. Others in-
clude damage to the superior laryngeal and hypoglossal
nerves, wound dehiscence, and cerebrospinal fluid leak-
age. It was reported [35, 36] that the overall rate of com-
plications was as high as 14–34% in the surgical
treatment of cervical spine tumors. The rate of compli-
cations associated with surgeries in this study was as low
as 12.82% (5/39) though the combined approach was
conducted in most of the cases (Table 1). In more detail,
complications associated with the anterior approach
were dysphagia and dysphonia in two patients, airway
obstruction and tracheotomy in one patient, respectively,
which was a relative low rate (4/39, 10.26%). The most
serious complication in our series was dyspnea in one
patient who died of airway obstruction. Hence, tracheal
extubation should be done after careful assessment of
the breathing status and meticulous preparation of
tracheotomy. Although complications are unavoidable in
some cases, efforts should be made to reduce complica-
tions via careful pre-operative evaluation, careful and
gentle operation, and post-operative close observation.
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To sum up, aggressive surgery is recommended for
atlantoaxial metastases since the advance in surgical
techniques and low incidence of complications and reli-
able outcomes.
Adjuvant therapy
Adjuvant therapies such as radiotherapy and chemother-
apy were mainly used in atlantoaxial metastases, while
the efficacy was limited [17]. In our study, pre-operative
adjuvant therapies were performed in 10 patients
(25.64%) before surgery. The timeframe of adjuvant ther-
apies was determined by the tumor types as well as the
urgency of symptoms. Generally speaking, according to
our experience, adjuvant therapies such as radiotherapy,
chemotherapy as well as targeted therapy were carried
out after the surgical intervention rather than before for
the immediate stabilization, pain relief, and the preven-
tion of possible neurologic deterioration as well as the
possible wound healing problem. Though all patients
were advised to receive post-operative adjuvant therapy
according to their pathologies and pre-operative treat-
ments, unfortunately, the compliance of receiving adju-
vant therapies was not very satisfactory in this study
(Table 1), which may in turn reveal the surgical efficacy
to some extent.
In summary, our experience and practice suggest that
more aggressive surgery should be considered in the
treatment of atlantoaxial metastases since the critical
function of atlantoaxil spine for people’s life. The main
goals of surgical intervention are to (a) relieve pain,
(b) restore immediate spinal stability, (c) prevent neuro-
logic deterioration, (d) obtain histological diagnosis, and
(e) increase the obedience for further adjuvant therapies.
Of course, some limitations of this study should be listed.
First, this study is a retrospective one, which is not as evi-
dent as a randomized controlled trial, through it is greatly
difficult to carry out. Second, the amount of patients col-
lected in this study is limited, and studies of more cases
are needed. In addition, the effect of adjuvant therapy in
this study was unable to be evaluated exactly. In all, stud-
ies including more cases, randomized controlled trial and
multiple-factor analysis are urgently required to gain the
treatment guidelines of upper cervical spine metastases.
Conclusions
Metastatic involvement of the upper cervical spine is rare
and intractable. Pain is the most common symptom. Rela-
tive radical surgical resection with effective stabilization
can achieve satisfactory outcomes with a low rate of mor-
tality and complication. Together with adjuvant manage-
ment, surgical treatment of atlantoaxial metastases can not
only relieve regional pain, restore, or improve neurologic
function but also stabilize the quality of life and prolong
the survival time of such patients.
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